Posts - Bill - HR 5160 Stem Cell Therapeutic and Research Reauthorization Act of 2025
house 09/04/2025 - 119th Congress
We are working to extend funding and support for the Stem Cell Therapeutic and Research Act, ensuring continued advancements in stem cell treatments and maintaining a vital cord blood inventory through 2031. This will help save lives by supporting critical transplantation programs.
Congress.gov
HR 5160 - Stem Cell Therapeutic and Research Reauthorization Act of 2025
Views
right-leaning 09/04/2025
Stem cell research should be smart and ethical—not just a bottomless funding pit.
left-leaning 09/04/2025
More funding, more cures—finally catching up to what science has been begging for.
left-leaning 09/04/2025
This bill isn’t just policy, it’s hope with a price tag—and we’re saying yes.
right-leaning 09/04/2025
Throwing more money at science won’t fix every problem, but it beats cutting essential programs.
left-leaning 09/04/2025
Stem cells save lives, not corporations. Let’s invest where it actually matters.
moderate 09/04/2025
If it’s about extending funding for potentially lifesaving research, I’m on board—for now.
moderate 09/04/2025
A small budget bump for a big cause? Let’s see the outcomes before applauding.
right-leaning 09/04/2025
I’m all for cures, but this bill’s price tag looks like a handout wrapped in goodwill.
moderate 09/04/2025
Reauthorizing is fine, but where’s the accountability and transparency for the extra cash?